Puma Biotechnology
(PBYI)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2013 | 12-2012 | 09-2012 | 06-2012 | 03-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,780 | -74,352 | -52,440 | -26,581 | -11,826 |
| Depreciation Amortization | 90 | 265 | 187 | 118 | 49 |
| Accounts receivable | -6,723 | -10,612 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 6,405 | 395 | 931 | 2,323 | 567 |
| Other Working Capital | -7,966 | 9,981 | 25,743 | 14,420 | 8,707 |
| Other Operating Activity | 1,493 | 30,311 | 6,376 | -1,839 | -282 |
| Operating Cash Flow | $-18,481 | $-44,012 | $-19,203 | $-11,559 | $-2,785 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -183 | -1,062 | -673 | -664 | -423 |
| Purchase Of Investment | -27,095 | N/A | N/A | N/A | N/A |
| Other Investing Activity | -1 | -159 | -159 | -157 | -1 |
| Investing Cash Flow | $-27,279 | $-1,221 | $-832 | $-821 | $-424 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 129,259 | N/A | N/A | N/A |
| Financing Cash Flow | $N/A | $129,259 | $N/A | $N/A | $N/A |
| Beginning Cash Position | 137,408 | 53,382 | 53,382 | 53,382 | 53,382 |
| End Cash Position | 91,648 | 137,408 | 33,347 | 41,002 | 50,173 |
| Net Cash Flow | $-45,760 | $84,026 | $-20,035 | $-12,380 | $-3,209 |
| Free Cash Flow | |||||
| Operating Cash Flow | -18,481 | -44,012 | -19,203 | -11,559 | -2,785 |
| Capital Expenditure | -183 | -1,062 | -673 | -664 | -423 |
| Free Cash Flow | -18,664 | -45,074 | -19,876 | -12,223 | -3,208 |